SCHEMBL28560824

SCHEMBL28560824

c1cc2sc(-c3ccsc3)nc2cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.50
RAB9A P51151 3/20 0.50
KDM4E B2RXH2 2/20 0.50
CYP2A6 P11509 4/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2B6 P20813 1/20 0.45
CYP2C19 P33261 1/20 0.45
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
PPARA Q07869 1/20 0.38
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
CYP17A1 P05093 1/20 0.38
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
MYC P01106 1/20 0.36
ILK Q13418 1/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23458507 0.84 RAB9A (0.68) NPC1RAB9AKDM4EILKCDC7
SCHEMBL26833283 0.78 RAB9A (0.64) NPC1RAB9AKDM4EILKALDH1A1
SCHEMBL3469331 0.78 RAB9A (0.64) NPC1RAB9AKDM4EILKALDH1A1
SCHEMBL28561310 0.78 NPC1 (0.54) NPC1RAB9AKDM4ECYP2A6CYP3A4
SCHEMBL29606206 0.78 RAB9A (0.64) NPC1RAB9AKDM4EILKALDH1A1
SCHEMBL25028306 0.78 KDM4E (0.43) NPC1RAB9AKDM4ECYP2A6PDGFRB
SCHEMBL20519963 0.77 RAB9A (0.76) NPC1RAB9AKDM4ECYP2A6CYP3A4
SCHEMBL221542 0.75 APP (0.63) NPC1RAB9AKDM4EALDH1A1GLA
SCHEMBL15164320 0.75 RAB9A (0.51) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL31670522 0.75 RAB9A (0.51) NPC1RAB9AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108373476-B Kinase inhibitor and preparation and application thereof 成都地奥制药集团有限公司 2021-06-01 CN disclosed